Burden of invasive squamous cell carcinoma of the penis in the United States, 1998-2003

Cancer

Volumn 113, Issue 10 SUPPL., 2008, Pages 2883-2891

  Hernandez, Brenda Y ^a   Barnholtz Sloan, Jill ^b   German, Robert R ^c   Giuliano, Anna ^d   Goodman, Marc T ^a   King, Jessica B ^c   Negoita, Serban ^e   Villalon Gomez, Jose M ^f  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^e NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^f JAMAICA HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Cancer; Human papillomavirus; Incidence; Mortality; Penile; Penis; Squamous cell carcinoma; United States

Indexed keywords

WART VIRUS VACCINE;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER MORTALITY; CANCER REGISTRY; HEALTH SURVEY; HISPANIC; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PENIS CARCINOMA; PRIORITY JOURNAL; RISK FACTOR; SOCIOECONOMICS; SQUAMOUS CELL CARCINOMA; UNITED STATES;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PENILE NEOPLASMS; REGISTRIES; UNITED STATES;

EID: 56449111341     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23743     Document Type: Article

References (37)

1. Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine. 2006;24(suppl 3):S11-S25.
2. Muir CS, Nectoux J. Epidemiology of cancer of the testis and penis. Natl Cancer Inst Monogr. November 1979;157-164.
3. Rippentrop JM, Joslyn SA, Konety BR. Squamous cell carcinoma of the penis: evaluation of data from the surveillance, epidemiology, and end results program. Cancer. 2004;101:1357-1363.
4. Barnholtz-Sloan JS, Maldonado JL, Pow-sang J, Guiliano AR. Incidence trends in primary malignant penile cancer. Urol Oncol. 2007;25:361-367.
5. Goodman MT, Hernandez BY, Shvetsov YB. Demographic and pathologic differences in the incidence of invasive penile cancer in the United States, 1995-2003. Cancer Epidemiol Biomarkers Prev. 2007;16:1833-1839.
6. Daling JR, Madeleine MM, Johnson LG, et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer. 2005;116:606-616.
7. Rubin MA, Kleter B, Zhou M, et al. Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol. 2001;159:1211-1218.
8. Lont AP, Kroon BK, Horenblas S, et al. Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int J Cancer. 2006;119:1078-1081.
9. Senba M, Kumatori A, Fujita S, et al. The prevalence of human papillomavirus genotypes in penile cancers from northern Thailand. J Med Virol. 2006;78:1341-1346.
10. Picconi MA, Eijan AM, Distefano AL, et al. Human papillomavirus (HPV) DNA in penile carcinomas in Argentina: analysis of primary tumors and lymph nodes. J Med Virol. 2000;61:65-69.
11. Bezerra AL, Lopes A, Santiago GH, Ribeiro KC, Latorre MR, Villa LL. Human papillomavirus as a prognostic factor in carcinoma of the penis: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. Cancer. 2001;91:2315-2321.
12. Bezerra AL, Lopes A, Landman G, Alencar GN, Torloni H, Villa LL. Clinicopathologic features and human papillomavirus dna prevalence of warty and squamous cell carcinoma of the penis. Am J Surg Pathol. 2001;25:673-678.
13. Heideman DA, Waterboer T, Pawlita M, et al. Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma. J Clin Oncol. 2007;25:4550-4556.
14. World Health Organization. HPV IARC monograph summary. Lancet Oncol. 2005;6:204.
15. Maden C, Sherman KJ, Beckmann AM, et al. History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst. 1993;85:19-24.
16. Carter JJ, Madeleine MM, Shera K, et al. Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. Cancer Res. 2001;61:1934-1940.
17. Tsen HF, Morgenstern H, Mack T, Peters RK. Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (United States). Cancer Causes Control. 2001;12:267-277.
18. World Health Organization. International Classification of Disease for Oncology. 3rd ed. Geneva, Switzerland: World Health Organization; 2003.
19. American College of Surgeons Commission on Cancer. Registry Operations and Data Standards (ROADS). Standards of the Commission on Cancer. Chicago, IL: American College of Surgeons; 1996.
20. Howe HL, Jamison PM, Havener L, Chen VW, Ries LAG. Site-specific comparison of summary stage 1977 and summary stage 2000 coding. Available at:http://www.naaccr. org/indexasp?Col_SectionKey511&Col_ContentID5397 2008 Accessed on June 6, 2007.
21. Berg J. Morphologic classification of human cancer. In: Schottenfeld D, Fraumeni JJ, eds. Cancer Epidemiology and Prevention. 2nd ed. New York, NY: Oxford University Press; 1996:28-44.
22. Watson M, Saraiya M, Ahmed F, et al. Using population-based cancer registry data to assess the burden of HPV-associated cancers in the United States: overview of methods. Cancer. 2008;113(10 suppl):2841-2854.
23. Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR. Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis. 2006;194:1044-1057.
24. Xu F, Markowitz LE, Sternberg MR, Aral SO. Prevalence of circumcision and herpes simplex virus type 2 infection in men in the United States: the National Health and Nutrition Examination Survey (NHANES), 1999-2004. Sex Transm Dis. 2007;34:479-484.
25. Svare EI, Kjaer SK, Worm AM, Osterlind A, Meijer CJ, van den Brule AJ. Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic. Sex Transm Infect. 2002;78:215-218.
26. Vaccarella S, Lazcano-Ponce E, Castro-Garduno JA, et al. Prevalence and determinants of human papillomavirus infection in men attending vasectomy clinics in Mexico. Int J Cancer. 2006;119:1934-1939.
27. Castellsague X, Bosch FX, Munoz N, et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med. 2002;346:1105-1112.
28. Baldwin SB, Wallace DR, Papenfuss MR, Abrahamsen M, Vaught LC, Giuliano AR. Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic. Sex Transm Dis. 2004;31:601-607.
29. Hernandez B, Wilkens L, Zhu X, et al. Circumcision and human papillomavirus infection in men: a site-specific comparison. J Infect Dis. 2008;197:787-794.
30. Brinton LA, Li JY, Rong SD, et al. Risk factors for penile cancer: results from a case-control study in China. Int J Cancer. 1991;47:504-509.
31. Kahn JA, Lan D, Kahn RS. Sociodemographic factors associated with high-risk human papillomavirus infection. Obstet Gynecol. 2007;110:87-95.
32. Ries LAG, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2004. Based on November 2006 SEER data submission, posted to the SEER website 2007. Available at: http://seer.cancer.gov/csr/1975_2004/ Accessed on June 6, 2007.
33. Maiche AG, Pyrhonen S. Clinical staging of cancer of the penis: by size? By localization? Or by depth of infiltration? Eur Urol. 1990;18:16-22.
34. Micali G, Nasca MR, Innocenzi D, Schwartz RA. Penile cancer. J Am Acad Dermatol. 2006;54:369-391.
35. McDougal WS. Advances in the treatment of carcinoma of the penis. Urology. 2005;66(5 suppl):114-117.
36. Goodman MT, Shvetsov YB, McDuffie K, et al. Hawaii cohort study of serum micronutrient concentrations and clearance of incident oncogenic human papillomavirus infection of the cervix. Cancer Res. 2007;67:5987-5996.
37. Goldie SJ, Kohli M, Grima D, et al. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst. 2004;96:604-615.